CID 139587345

Lacticin 481

Structural Information

Molecular Formula
C127H182N36O35S4
SMILES
CCC(C)C1C(=O)NC2CSCC3C(=O)NC(CSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N/C(=C\C)/C(=O)N3)CC4=CC=CC=C4)C(C)C)CC5=CC=CC=C5)CCC(=O)N)CC6=CNC7=CC=CC=C76)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(CSC(C(C(=O)N1)NC(=O)C(CC8=CNC=N8)NC(=O)C(C(C)CC)NC(=O)C(C(C)C)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)CNC(=O)C(CCCCN)N)C)NC(=O)C(NC(=O)C(NC2=O)CC9=CNC=N9)CCC(=O)O)CC(=O)N)CCSC)CC(=O)N)C(=O)NC(CO)C(=O)O
InChI
InChI=1S/C127H182N36O35S4/c1-12-63(8)101(161-123(193)99(61(4)5)159-97(171)51-138-105(175)85(52-164)141-96(170)50-136-95(169)49-137-104(174)72(129)30-23-24-37-128)124(194)152-82(43-70-48-134-60-140-70)116(186)163-103-65(10)202-58-91-121(191)150-83(44-93(131)167)113(183)145-77(36-38-199-11)109(179)149-84(45-94(132)168)114(184)155-87-54-200-55-88(119(189)153-86(53-165)127(197)198)156-120(190)89(56-201-57-90(158-125(195)102(64(9)13-2)162-126(103)196)118(188)148-81(42-69-47-133-59-139-69)112(182)144-76(108(178)157-91)33-35-98(172)173)154-106(176)73(14-3)142-110(180)78(39-66-25-17-15-18-26-66)151-122(192)100(62(6)7)160-115(185)79(40-67-27-19-16-20-28-67)146-107(177)75(32-34-92(130)166)143-111(181)80(147-117(87)187)41-68-46-135-74-31-22-21-29-71(68)74/h14-22,25-29,31,46-48,59-65,72,75-91,99-103,135,164-165H,12-13,23-24,30,32-45,49-58,128-129H2,1-11H3,(H2,130,166)(H2,131,167)(H2,132,168)(H,133,139)(H,134,140)(H,136,169)(H,137,174)(H,138,175)(H,141,170)(H,142,180)(H,143,181)(H,144,182)(H,145,183)(H,146,177)(H,147,187)(H,148,188)(H,149,179)(H,150,191)(H,151,192)(H,152,194)(H,153,189)(H,154,176)(H,155,184)(H,156,190)(H,157,178)(H,158,195)(H,159,171)(H,160,185)(H,161,193)(H,162,196)(H,163,186)(H,172,173)(H,197,198)/b73-14-
InChIKey
VIEVUPYQRUJFFA-XFKIZFQISA-N
Compound name
2-[[(8Z)-29,35-bis(2-amino-2-oxoethyl)-20-(3-amino-3-oxopropyl)-11,17-dibenzyl-45-butan-2-yl-53-(2-carboxyethyl)-42-[[2-[[2-[[2-[[2-[[2-[[2-[[2-(2,6-diaminohexanoylamino)acetyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]acetyl]amino]-3-methylbutanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-8-ethylidene-50-(1H-imidazol-4-ylmethyl)-23-(1H-indol-3-ylmethyl)-41-methyl-32-(2-methylsulfanylethyl)-7,10,13,16,19,22,25,28,31,34,37,43,46,48,51,54,61-heptadecaoxo-14-propan-2-yl-3,40,57-trithia-6,9,12,15,18,21,24,27,30,33,36,44,47,49,52,55,60-heptadecazatricyclo[36.9.8.65,26]henhexacontane-59-carbonyl]amino]-3-hydroxypropanoic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

122
References

0
Patents

2899.245 Da
Monoisotopic Mass

-10.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2900.2523 267.4
[M+Na]+ 2922.2342 267.1
[M-H]- 2898.2377 266.6
[M+NH4]+ 2917.2788 264.8
[M+K]+ 2938.2082 260.0
[M+H-H2O]+ 2882.2423 251.1
[M+HCOO]- 2944.2432 264.7
[M+CH3COO]- 2958.2589 265.5
[M+Na-2H]- 2920.2197 282.6
[M]+ 2899.2445 252.3
[M]- 2899.2455 252.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.